Cite

HARVARD Citation

    Blennow, K. et al. (2019). CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD. Journal of neurology, neurosurgery and psychiatry. 90 (8), pp. 846-853. [Online]. 
  
Back to record